Share Capital (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Share Capital [Abstract] |
|
| Schedule of Change in Stock Options |
The following table shows the change in stock options during the fifteen months ended December 31, 2025 and twelve months ended September 30, 2024: | | | December 31, 2025 | | | September 30, 2024 | | | | | Number of
options | | | Weighted
average
exercise price | | | Number of
options | | | Weighted
average
exercise price | | | Balance, start of the year | | | 2,575,000 | | | $ | 0.52 | | | | 1,625,000 | | | $ | 0.51 | | | Granted | | | 6,020,000 | | | | 0.87 | | | | 1,737,500 | | | | 0.56 | | | Exercised | | | (1,400,000 | ) | | | 0.50 | | | | – | | | | – | | | Forfeited/expired/cancelled | | | (475,000 | ) | | | 0.66 | | | | (787,500 | ) | | | 0.58 | | | Balance, end of the year | | | 6,720,000 | | | $ | 0.83 | | | | 2,575,000 | | | $ | 0.52 | |
|
| Schedule of Option Pricing Model for Options Granted |
The assumptions used in the Black-Scholes option pricing model for the options granted in the fifteen months ended December 31, 2025 and twelve months ended September 30, 2024 were as follows. | Weighted average | | Fifteen months ended
December 31, 2025 | | | Twelve months ended
September 30, 2024 | | | Exercise price per share issuable | | $ | 0.87 | | | $ | 0.56 | | | Expected term (years) | | | 5 | | | | 3 | | | Volatility | | | 91% | | | | 125% | | | Expected dividend yield | | | – | | | | – | | | Risk-free interest rate | | | 2.39% | | | | 2.90% | | | Weighted average fair value per option | | | 0.61 | | | | 0.36 | |
|
| Schedule of Outstanding and Exercisable Stock Options |
The following is a summary of the Company’s outstanding and exercisable stock options as at December 31, 2025: | Outstanding | | Exercisable | | | Expiry date | | Exercise
price | | | Number of
options | | | Weighted
average
remaining
contractual life
(years) | | | Number of
options | | | Weighted
average
remaining
contractual life
(years) | | | November 3, 2026 | | $ | 0.60 | | | | 75,000 | | | | 0.84 | | | | 75,000 | | | | 0.84 | | | March 12, 2027 | | | 0.55 | | | | 600,000 | | | | 1.19 | | | | 600,000 | | | | 1.19 | | | March 3, 2028 | | | 0.42 | | | | 175,000 | | | | 2.17 | | | | 175,000 | | | | 2.17 | | | October 21, 2029 | | | 0.80 | | | | 4,220,000 | | | | 3.81 | | | | 2,030,000 | | | | 3.81 | | | January 2, 2030 | | | 1.04 | | | | 1,600,000 | | | | 4.01 | | | | – | | | | 4.01 | | | April 7, 2030 | | | 1.90 | | | | 50,000 | | | | 4.27 | | | | – | | | | 4.27 | | | | | $ | 0.83 | | | | 6,720,000 | | | | 3.55 | | | | 2,880,000 | | | | 3.09 | |
|
| Schedule of Continuity of Company’s Warrants |
A continuity of the Company’s warrants is as follows: | | | Number of
warrants | | | Weighted
average exercise
price | | | Outstanding, September 30, 2023 | | | – | | | $ | – | | | Issued | | | 30,000,000 | | | | 0.15 | | | Exercised | | | (25,000 | ) | | | 0.15 | | | Outstanding, September 30, 2024 | | | 29,975,000 | | | $ | 0.15 | | | Exercised | | | (734,702 | ) | | | 0.15 | | | Outstanding, December 31, 2025 | | | 29,240,298 | | | $ | 0.15 | |
|